MYC and leukemia: While previous investigations have primarily focused on benzene-induced lymphoblastoid cell transformation and associated immune evasion mechanisms, our study specifically elucidates the novel regulatory axis between c-Myc and PD-L1 in immune escape processes, providing critical insights for developing targeted therapies against benzene-related leukemia.